Biotechnology · Emeryville, California, United States
n/a
Revenue$2.3M
Net Income-$1.2M
EPS$1.42
Gross Margin65.0%
Price Performance
Historical data including institutional events
Loading price data...
Company Profile
M
Michael Kazley
CEO & Executive Director
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks.
The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities.
The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007.
NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.